Decreasing mortality rate in early pneumonia following hematopoietic stem cell transplantation

References

• Chen CS, Boeckh M, Seidel K, Clark JG, Kansu E, Madtes DK, et al. Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation. Bone Marrow Transplantation 2003; 32: 515
   PubMed Web of Science ®Google Scholar
• Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, Cividalli G, et al. Non-myeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and non-malignant haematological diseases. Blood 1998; 91: 756
   PubMed Web of Science ®Google Scholar
• Hentschke P, Barkholt L, Uzunel M, Mattsson J, Wersäll P, Pisa P, et al. Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma. Bone Marrow Transplantation 2003; 31: 253
   PubMed Web of Science ®Google Scholar
• Ringdén O, Pihlstedt P, Markling L, Aschan J, Båryd I, Ljungman P, et al. Prevention of graft-versus-host disease with T-cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukaemic marrow recipients. Bone Marrow Transplantation. 1991; 7: 221
   PubMed Web of Science ®Google Scholar
• Storb R, Deeg H, Whitehead J, Appelbaum F, Beatty P, Bensinger W, et al. Methotrexate and cyclosporin compared with cyclosporin alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukaemia. New England Journal of Medicine 1986; 314: 729
   PubMed Web of Science ®Google Scholar
• Sparrelid E, Hägglund H, Remberger M, Ringdén O, Lönnqvist B, Ljungman P, et al. Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection. Bone Marrow Transplantation. 1998; 22: 795
   PubMed Web of Science ®Google Scholar
• Ljungman P, Lore K, Aschan J, Klaesson S, Lewensohn-Fuchs I, Lönnqvist B, et al. Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients. Bone Marrow Transplantation. 1996; 17: 583
   PubMed Web of Science ®Google Scholar
• Ljungman P, Aschan J, Lewensohn-Fuchs I, Carlens S, Larsson K, Lönnqvist B, et al. Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients. Transplantation 1998; 66: 1330
   PubMed Web of Science ®Google Scholar
• Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clinical Infectious Diseases 2002; 34: 1094
   PubMed Web of Science ®Google Scholar
• Einsele H, Ehninger G, Hebart H, Wittkowski KM, Schuler U, Jahn G, et al. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side-effects of antiviral therapy after bone marrow transplantation.[see comment]. Blood 1995; 86: 2815
   PubMed Web of Science ®Google Scholar
• Dettenkofer M, Wenzler-Rottele S, Babikir R, Bertz H, Ebner W, Meyer E, et al. Surveillance of nosocomial sepsis and pneumonia in patients with bone marrow or peripheral blood stem cell transplant: a multicentre project. Clin Infect Dis 2005; 40: 926
   PubMed Web of Science ®Google Scholar
• Walter EA, Bowden RA. Infection in the bone marrow transplant recipient. Infectious Disease Clinics of North America 1995; 9: 823
   PubMed Web of Science ®Google Scholar
• Martino R, Manteiga R, Sanchez I, Brunet S, Sureda A, Badell I, et al. Viridans streptococcal shock syndrome during bone marrow transplantation. Acta Haematologica 1995; 94: 69
   PubMed Web of Science ®Google Scholar
• Morris JG, Jr, Shay DK, Hebden JN, McCarter RJ, Jr, Perdue BE, Jarvis W, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical centre. Annals of Internal Medicine 1995; 123: 250
   PubMed Web of Science ®Google Scholar
• Winston DJ, Maziarz RT, Chandrasekar PH, Lazarus HM, Goldman M, Blumer JL, et al. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicentre, randomized trial [see comment]. Annals of Internal Medicine 2003; 138: 705
   PubMed Web of Science ®Google Scholar
• Marmont AM, Gale RP, Sobocinski K, Ash RC, van Bekkum D, Champlin RE, et al. T-cell depletion of HLA-identical transplants in leukaemia. Blood 1991; 78: 2120
   PubMed Web of Science ®Google Scholar
• Castagena E, Cappelli B, Erba D, Rabagliati A, Lanino E, Dini G. Cytomegalovirus infection after bone marrow transplantation in children. Hum Immunology 2004; 65: 416
   PubMed Web of Science ®Google Scholar
• Grob J, Grundy J, Prentice H. Interstitial pneumonitis in recipients of HLA-matched T-depleted BMT: apparent effect of received lung TBI-dose. Bone Marrow Transplantation 1986:49 (Suppl1).
   Google Scholar
• Della Volpe A, Ferreri AJ, Annaloro C, Mangili P, Rosso A, Calandrino R, et al. Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with haematological malignancies treated with total body irradiation. Int J Radiat Oncol Biol Phys 2002; 52: 483
   PubMed Web of Science ®Google Scholar
• Savani BM, Montero A, Wu C, Nlonda N, Read E, Dunbar C, et al. Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 223
   PubMed Web of Science ®Google Scholar
• Ljungman P, Brand R, Einsele H, Frassoni F, Niederwieser D, Cordonnier C. Donor CMV serological status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis. Blood 2003; 102: 4255
   PubMed Web of Science ®Google Scholar
• Broers AE, van Der Holt R, van Esser JW, Gratama JW, Henzen-Logmans S, Kuenen-Boumeester V, et al. Increased transplant-related mortality and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation. Blood 2000; 95: 240
   Web of Science ®Google Scholar
• Sharma S, Nadrous HF, Peters SG, Tefferi A, Litzow MR, Aubry MC, Afessa B. Pulmonary complications in adult blood and marrow transplant recipients: autopsy findings. Chest 2005; 128: 1385
   PubMed Web of Science ®Google Scholar
• Raboni SM, Nogueire MB, Tsuchiya LR, Takahashi GA, Pereira LA, Pasquini R, Siqueira MM. Respiratory tract viral infections in bone marrow transplant patients. Transplantation 2003; 76: 142
   PubMed Web of Science ®Google Scholar
• Nusair S, Breuer R, Shapira MY, Berkman N, Or R. Low incidence of pulmonary complications following non-myeloablative stem cell transplantation. Eur Respir J 2004; 23: 440
   PubMed Web of Science ®Google Scholar